Abstract -Biologically important (2R)-2-amino-3-phenylpropanes consisted in commercial drugs including (R,R)-formoterol, and (R)-tamsulosin were prepared from chiral (2R)-aziridine-2-carboxylate without any chromatographic separation.
Both of those two compounds (1 and 2) are able to be elaborated from 4-methyloxazolidin-2-ones by reductive hydrogenation that would be formed from vicinal amino alcohol. The possible common synthetic intermediates (4R)-4-methyl-5-phenyloxazolidin-2-one will be derived from regio-and stereoselective ring opening product of aziridin-2-yl-phenylmethanol originated from commercial (-)-menthyl aziridine-2-carboxylate in optically pure form. In this report is described an efficient asymmetric formal synthesis of commercial drugs formoterol and tamsulosin in gram-scale without chromatograph.
The main theme of this synthesis involves an efficient preparation of the synthetic intermediate (4R)-4-methyl-5-(4-methoxyphenyl)oxazolidin-2-one (8) , from which (4R)-5-(4-methoxy-3-sulfamoylphenyl)-4-methyloxazolidin-2-one (9) is derived. First of all commercial (2R)-aziridine-2-carboxylate (3) 7 was treated with Weinreb'a amine whose product 4 was isolated and purified by crystallization from n-hexane in 89% yield. Addition of 4-methoxyphenylmagnesium bromide was followed to yield an acylaziridine (5) . Reduction of acylaziridine 8 with NaBH 4 afforded 6 which was isolated as crystalline solid from n-hexane in 86% yield for two steps. Aziridin-2-yl-phenylmethanol (6) was hydrogenated in the presence of di-t-butyl dicarbonate ((Boc) 2 O) to produce acyclic aminopropanol 7 in 89% yield (Scheme 1). Aminopropanol (7) with t-butoxycarbonyl (Boc) as an amine protecting group was treated with sodium hydride to give cyclized product 8 that was isolated as a crystalline solid form in 78% yield. This was reacted with chlorosulfonic acid in slow addition controlling the temperature not to be higher than 10ºC followed by addition of ammonia to give 9. Both compounds 8 and 9 were treated with either hydrogen gas or ammonium formate in the presence of palladium on carbon to yield 1 and 2 respectively in more than 87% yields. and cooled down to -78 ºC. Into this solution was added ZnCl 2 (9.6 g, 70 mmol) and NaBH 4 (3.3 g, 88 mmol). The resultant solution was stirred for 0.5 h before adding 10 mL of water. The resultant solution was concentrated under reduced pressure and the residue was dissolved in 300 mL EtOAc. The organic layer was washed with water twice (150 mL x 2), dried by anhydrous MgSO 4 and concentrated with the removal of all solvent. This crude product in liquid was dissolved in n-hexane (20 mL) and kept at 0 ºC for 20 h. The crystalline products (13.2 g) was filtered and dried. In the mother liquor lots of products was left which was combined together with the next batch of the reaction to isolate the products. 
(1S,2R)-2-[N-(t-Butoxycarbonyl)amino]-1-(4-methoxyphenyl)propanol (7).
(2R,1'S,1''R)-(1''-Phenylethyl)aziridine-2-yl-[1'-(4-methoxyphenyl)]methanol (6, 13.0 g, 45.8 mmol) and di-t-butyl dicarbonate (10 g, 45.8 mmol) were dissolved in EtOH (92 mL). Into this solution was added Pd(OH) 2 (2.6 g) and the resultant solution was stirred for 8 h under atmospheric pressure of H 2 at rt. The solution was filtered and concentrated under in vacuo to yield crude product. Purification was carried out by crystallization from n-hexane (13 mL) to yield 11.5 g solid product in 89% yield. 
(4R,5S)-5-(4-Methoxyphenyl)-4-methyloxazolidin-2-one (8).
To the solution of (1S, 2R)-2-[N-(t-butoxycarbonyl)amino]-1-(4-methoxyphenyl)propanol (7, 11.3 g, 40 mmol) in THF (130 mL) was added NaH (1.2 g, 50 mmol) . The resultant solution was stirred for 24 h before adding 5 mL of water. Then this solution was concentrated under reduced pressure. The mixture was extracted with EtOAc twice (100 mL x 2). The combined organic extracts were washed successively with water (100 mL) and saturated aqueous NaHCO 3 (100 mL), dried by anhydrous MgSO 4 , filtered, and concentrated under reduced pressure. This crude product in liquid was dissolved in n-hexane (7 mL) and kept at 0 ºC for 20 h. The crystalline products (6.5 g) was filtered and dried. 
4R,5S)-5-(4-Methoxy-3-sulfamoylphenyl)-4-methyloxazolidin-2-one (9).
To the solution of (1S, 2R)-5-(4-methoxyphenyl)-4-methyloxazolidin-2-one (8, 1.5 g, 7.2 mmol) was added slowly chlorosulfonic acid (26.3 mg, 225 mmol) at 0 ºC. This solution was stirred for 0.5 h at 0 ºC before addition of 10 mL ice water. The reaction product was extracted with EtOAc (50 mL x 2). The organic layer was washed successively with water (30 mL) and saturated aqueous NaHCO 3 (30 mL), dried by anhydrous MgSO 4 , filtered, and concentrated under reduced pressure. The concentrated organic material was dissolved in 20 mL THF that was bubbled by anhydrous ammonia gas until all starting material was gone. This crude product was concentrated again under reduced pressure and crystallized from n-hexane ( 
